DailyDoctor Archive Specialties Get app
All anaesthesiology briefings

The edition · Anaesthesiology

Turning down fresh gas flow is what cuts sevoflurane's carbon; the absorbent barely registers

Across 0.2 to 4 l/min, sevoflurane accounted for over 97% of the first hour's emissions. Plus intravenous lidocaine in spine surgery by procedure, little-finger versus thumb neuromuscular monitoring, fospropofol and early nausea, and a Class II recall of lidocaine ointment.

The edition in brief

Pooling 132 patients from three studies, an Anesthesiology analysis found first-hour sevoflurane emissions rose linearly with fresh gas flow, from 2.4 to 18.6 kg CO2 equivalent between 0.2 and 4 l/min, while carrier gas and carbon dioxide absorbent together contributed under 3% even in closed-circuit delivery; lowering flow and end-tidal concentration is what matters. A meta-analysis of 10 randomised trials found perioperative intravenous lidocaine reduced 24-hour pain after spine surgery by 0.83 points and morphine use by 11.6 mg, with a clinically meaningful effect after instrumented fusion and complex surgery but almost none after decompression, a post hoc finding. A randomised comparison in 44 patients found electromyographic monitoring at the abductor digiti minimi matched the adductor pollicis for rocuronium onset and sugammadex recovery, except on the dominant hand, where the little finger recovered about 90 seconds early. In 102 high-risk women having gynaecological laparoscopy, fospropofol cut nausea and vomiting in the first six hours (5.9% vs 19.6%) compared with propofol, with no difference at 24 hours and slower extubation. The FDA lists an ongoing Class II recall of a lidocaine 5% ointment from Taro for failing content uniformity at stability testing. The pearl covers checking the train-of-four ratio before extubation.

In this edition
01
Clinical update

Intravenous lidocaine eased pain after spinal fusion but did little after decompression

Consider intravenous lidocaine for analgesia after instrumented or complex spine surgery, not routine decompression.

2 min · Regional anesthesia and pain medicineRead →
Primary outcome
Pain intensity at 24 hours
Effect
MD −0.83 (95% CI −1.36 to −0.30); fusion or complex −1.23 (−1.81 to −0.64); decompression −0.20 (−0.61 to 0.21)
02Research

Little-finger EMG monitoring matched the thumb, except on the dominant hand

Little-finger EMG monitoring is acceptable on the non-dominant hand; on the dominant hand it may overstate recovery.

1 min · AnesthesiologyRead →
03Research

Fospropofol reduced early nausea after gynaecological laparoscopy, but not at 24 hours

Fospropofol reduced early nausea in a small trial; continue multimodal prophylaxis for high-risk patients.

1 min · Drug design, development and therapyRead →
04Regulatory

Class II recall of a lidocaine 5% ointment for failing content uniformity

If you stock the named Taro lidocaine 5% ointment, check lots against the recall and quarantine affected jars.

1 minRead →
05Pearl

Measure a train-of-four ratio of at least 0.9 before extubation

Extubate only after a measured train-of-four ratio of 0.9 or more.

1 minRead →
06
Practice changer

Sevoflurane's emissions rose almost eightfold with fresh gas flow; carrier gas and absorbent were trivial

Lower fresh gas flow and end-tidal concentration to cut sevoflurane emissions; absorbent use is not a reason to keep flows high.

2 min · AnesthesiologyRead →
Primary outcome
First-hour CO2 equivalent emissions by component
Effect
Sevoflurane 2.4 to 18.6 kg CO2e across flows; carrier gas plus absorbent under 3% of total

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

Tomorrow morning, before your first patient

One edition a day for anaesthesiology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free